- New offices in Chile and Peru, expansion of Argentina office increase access to patients to reduce drug development timelines for biopharmaceutical companies -
PRINCETON, N.J., April 7 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced the recent opening of new clinical development offices in Santiago, Chile, and Lima, Peru, and the expansion of the company's Buenos Aires, Argentina office. These latest office openings further extend the company's global clinical development presence to increase patient access and reduce clinical development timelines.
Covance has been providing clinical trial support in Latin America since 1997 with the company's first office in Buenos Aires, Argentina. Operations in Latin America expanded quickly with the organization of an extensive and highly-trained network of regional clinical trial monitors. The new clinical offices located in Santiago and Lima will support staff in Chile and Peru, including Covance's regional network of field-based clinical research associates throughout Latin America.
"Our strategy is to target areas for qualified patient populations and the most qualified investigators as we selectively expand our presence in key metropolitan centers in emerging regions such as Latin America," said Katie Margules, Covance's senior director of project management in Latin America. "Our focus continues to be on delivering outstanding drug development and building stronger strategic relationships with our clients."
The new offices and expanded facilities in Latin America will help Covance expedite the execution of clinical studies with a full range of services, and build strategic relationships with investigators, sites, and regulatory authorities in a region known for its strong potential to contribut
|SOURCE Covance Inc.|
Copyright©2009 PR Newswire.
All rights reserved